The Broad Institute is a genomic medicine research center located in Cambridge, Massachusetts, United States. Although it is independently governed and supported as a 501(c)(3) nonprofit research ...
R esearchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50% in a mouse model of the fatal neurodegenerative ...
Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...
Scientists at the Broad Institute of MIT and Harvard, Harvard Medical School, and McLean Hospital have discovered a surprising mechanism by which the inherited genetic mutation known to cause ...
The Broad Institute of MIT and Harvard is partnering with Manifold to bring a unique life science research and development platform to investigators around the world. Healthcare data have become ...
Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends lifespan by about 50 percent in a mouse model of the fatal ...
Summary: A team of investigators from Dana-Farber Cancer Institute, The Broad Institute of MIT and Harvard, Google, and ...
A multi-modal transformer for cell type agnostic regulatory predictionsPublication: Cell Genomics , January 29, 20225Dana-Farber Cancer ...
The Trump administration's proposed freeze on federal funding raises concerns among universities, but Harvard and MIT are well-positioned to weather the storm. Their massive endowments ensure ...
Boston researchers found a link between ultra-processed meats and memory loss. Reporter Kay Lazar cuts through the fat. Regularly eating red meat has been linked with heart disease, diabetes, and ...
Founded by MIT, Harvard, Harvard-affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students ...
Researchers have discovered that about 5% of adult cancers rely on a gene called PELO to survive, offering a promising drug ...